Kit Check’s Agreement with Vizient Extended in Multi-Year Contract, Providing Better Visibility in Drug Diversion and Medication Tracking

Jenny HarlettPress Release

WASHINGTON (October 3, 2019) — Kit Check, the leader in automated medication management solutions for hospitals, today announced that Vizient has extended its agreement with the company for its Bluesight for Controlled Substances (BCS) as well as Kit Check’s kit and tray processing system. Vizient is the nation’s leading health care performance improvement company serving more than 50% of the … Read More

Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring

Jenny HarlettPress Release

Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 WASHINGTON (August 20, 2019) — Kit CheckTM, the leader in automated medication management solutions for hospitals, today announced that its Bluesight for Controlled Substances (Bluesight) diversion prevention and controlled substance management solution has been recognized by leading analyst firm KLAS Research in its next-generation solution … Read More

Bluesight for Controlled Substances Takes Top Score for Emerging Solutions in New KLAS Report

Jenny HarlettBlog

Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. We are thrilled to announce that Bluesight for Controlled Substances received top marks, earning a rating of 93.2* out of 100! KLAS’s “Drug Diversion Monitoring 2019, An Early Look at Emerging Vs. Established Technology” highlights hospitals and health systems’ need for drug diversion monitoring technology, … Read More

New Bluesight for Controlled Substances Feature: Investigation Portfolios

Jenny HarlettBlog

We are excited to announce the launch of our newest feature for the Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Designed to support ASHP investigation guidelines, the Investigations Portfolio dashboard allows hospital diversion teams to collaborate with each other throughout the process, ensuring thorough, unbiased investigations and adherence to established procedures. Many hospitals … Read More

Kit Check Announces the Latest Bluesight for Controlled Substances Feature, Investigation Portfolios

Jenny HarlettPress Release

Workflow collaboration tool helps hospitals locate possible diverters with accuracy Washington DC, June 25, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, today announced the addition of a new feature to its Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Bluesight for Controlled Substances’ Investigation Portfolios tool was designed … Read More

The Data Science Behind Drug Diversion Detection with Bluesight for Controlled Substances

Jenny HarlettBlog

Data science has emerged as an ally for hospital directors of pharmacy in the continuous effort to close the “diversion gap”—the space where tracking and controls are incomplete and diverters conceal their activity. Simple math such as standard deviation and averages have proven inadequate in identifying controlled substance diverters who have become adept at covering their tracks. However, new machine … Read More

50 Hospitals Adopt Bluesight for Controlled Substances to Reconcile Discrepancies Faster, Implement 100% Audit and Close the Diversion Gap

Ramsey ChambersBlog

Kit Check introduced Bluesight for Controlled Substances (BCS) in 2017 at ASHP Midyear. At the time, we had three hospitals that were using the solution as development partners. We arrive today at ASHP one year later with more than 50 hospitals using BCS. After refining the hospital automated auditing solution in the first half of 2018, we started to make … Read More

Video: How to Close the Diversion Gap

Bret KinsellaBlog

Kevin MacDonald, co-founder and CEO of Kit Check, at the Heath Connect Partners fall conference in Chicago discussed the origin of the “Diversion Gap” and how to close it. The “gap” is caused by the fact that systems employed to track controlled substance storage and use in hospitals are not integrated. In addition, no tools exist to adequately identify when anomalies arise … Read More

ZDNet Interviews Kevin MacDonald On Using AI to Prevent Opioid Diversion

Ava MutchlerBlog

Over 500 hospitals now use Kit Check’s automated medicated management solution to track medications from the pharmacy to other procedural and emergency areas in the hospital. ZDNet recently interviewed CEO Kevin MacDonald on how on the large amount of data acquired with its first solution led Kit Check to its next solution: Bluesight for Controlled Substances (BCS). “What we kept … Read More

ZDNet Video Interview: How machine learning and AI can help detect opioid theft

Ava MutchlerBlog

The misuse and addiction of opioids has sparked a crisis across the United States, including those on the front lines: hospital administrators. Tonya Hall of ZDNet sat down with Kit Check’s Chief Product and Engineering officer Cameron Ferroni to discuss how the company’s latest product offering, Bluesight for Controlled Substances, is using AI and machine learning to help hospital leadership … Read More

Bluesight for Controlled Substances screenshot

Kit Check Closes the Diversion Gap with Launch of Bluesight IRIS and Reveals Which Hospital Employees Exhibit Behaviors Consistent with Controlled Substance Theft

Ava MutchlerPress Release

Leading Automated Medication Solutions Provider for Hospital Pharmacies Leverages Machine Learning to Enhance Diversion Identification and Curb Opioid Misuse in Hospitals WASHINGTON (October 1, 2018) – Kit Check, the leader in automated medication management solutions for hospitals, today announced the addition of Individual Risk Identification Score (IRIS) to its keystone medication diversion platform. The latest feature of Kit Check’s Bluesight … Read More